Literature DB >> 34347960

CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.

Dimitrios Mougiakakos1, Gerhard Krönke1, Simon Völkl1, Sascha Kretschmann1, Michael Aigner1, Soraya Kharboutli1, Sebastian Böltz1, Bernhard Manger1, Andreas Mackensen1, Georg Schett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34347960     DOI： 10.1056/NEJMc2107725

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  CAR-based therapies: opportunities for immuno-medicine beyond cancer.

Authors:  Haig Aghajanian; Joel G Rurik; Jonathan A Epstein
Journal:  Nat Metab       Date:  2022-02-28

2.  [German research groups are at the forefront in the application of innovative treatments of systemic lupus erythematosus].

Authors:  Christof Specker; Rebecca Fischer-Betz; Andreas Krause; Hendrik Schulze-Koops
Journal:  Z Rheumatol       Date:  2021-12-22       Impact factor: 1.372

3.  Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Authors:  Andreas Mackensen; Fabian Müller; Dimitrios Mougiakakos; Gerhard Krönke; Georg Schett; Sebastian Böltz; Artur Wilhelm; Michael Aigner; Simon Völkl; David Simon; Arnd Kleyer; Luis Munoz; Sascha Kretschmann; Soraya Kharboutli; Regina Gary; Hannah Reimann; Wolf Rösler; Stefan Uderhardt; Holger Bang; Martin Herrmann; Arif Bülent Ekici; Christian Buettner; Katharina Maria Habenicht; Thomas H Winkler
Journal:  Nat Med       Date:  2022-09-15       Impact factor: 87.241

Review 4.  Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy.

Authors:  Baixin Ye; Yongxian Hu; Mingming Zhang; He Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-25

Review 5.  Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Tobias Alexander; Raffaella Greco
Journal:  Bone Marrow Transplant       Date:  2022-05-16       Impact factor: 5.174

6.  Expert Perspective: An Approach to Refractory Lupus Nephritis.

Authors:  Swati Arora; Brad H Rovin
Journal:  Arthritis Rheumatol       Date:  2022-04-25       Impact factor: 15.483

Review 7.  Membranous nephropathy: new pathogenic mechanisms and their clinical implications.

Authors:  Elion Hoxha; Linda Reinhard; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2022-04-28       Impact factor: 42.439

Review 8.  Engineered cellular immunotherapies in cancer and beyond.

Authors:  Amanda V Finck; Tatiana Blanchard; Christopher P Roselle; Giulia Golinelli; Carl H June
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

Review 9.  Tailored treatment strategies and future directions in systemic lupus erythematosus.

Authors:  Dionysis Nikolopoulos; Lampros Fotis; Ourania Gioti; Antonis Fanouriakis
Journal:  Rheumatol Int       Date:  2022-04-21       Impact factor: 3.580

10.  Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study.

Authors:  Akihiro Hoshino; Etsushi Toyofuku; Noriko Mitsuiki; Motoi Yamashita; Keisuke Okamoto; Michio Yamamoto; Kenji Kanda; Genki Yamato; Dai Keino; Yuri Yoshimoto-Suzuki; Junji Kamizono; Yasuhiro Onoe; Takuya Ichimura; Mika Nagao; Masaru Yoshimura; Koji Tsugawa; Toru Igarashi; Kanako Mitsui-Sekinaka; Yujin Sekinaka; Takehiko Doi; Takahiro Yasumi; Yozo Nakazawa; Masatoshi Takagi; Kohsuke Imai; Shigeaki Nonoyama; Tomohiro Morio; Sylvain Latour; Hirokazu Kanegane
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.